1-anilino-8-naphthalenesulfonate has been researched along with Hyperlipoproteinemia Type IV in 10 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Hyperlipoproteinemia Type IV: A hypertriglyceridemia disorder, often with autosomal dominant inheritance. It is characterized by the persistent elevations of plasma TRIGLYCERIDES, endogenously synthesized and contained predominantly in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). In contrast, the plasma CHOLESTEROL and PHOSPHOLIPIDS usually remain within normal limits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acipimox was given at a dose of 750 mg/day for the first 6 months and 1200 mg/day for the last period." | 2.66 | Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia. ( Nikkilä, EA; Taskinen, MR, 1988) |
| "Ten patients with type III and 10 with type IV hyperlipoproteinemia participated in a comparative open cross-over study of the effect of acipimox (750 mg/day) and clofibrate (2 g/day) on lipoproteins, apoliproproteins and postheparin lipase activities during 6 weeks." | 2.66 | A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia. ( Demacker, PN; Stalenhoef, AF; Stuyt, PM; Van 't Laar, A, 1985) |
| "In subjects with primary lipoprotein lipase deficiency (n = 4), apo E was confined to fractions I and III." | 1.27 | Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. ( Brown, WV; Gibson, JC; Ginsberg, HN; Kakis, G; Little, A; Paterniti, JR; Rubinstein, A, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ENGELBERG, H | 2 |
| Schonfeld, G | 1 |
| Eklund, B | 1 |
| Söderberg, B | 1 |
| Taskinen, MR | 1 |
| Nikkilä, EA | 1 |
| Hopkins, GJ | 1 |
| Barter, PJ | 1 |
| Carlson, LA | 1 |
| Holmquist, L | 1 |
| Nilsson-Ehle, P | 1 |
| Stuyt, PM | 1 |
| Stalenhoef, AF | 1 |
| Demacker, PN | 1 |
| Van 't Laar, A | 1 |
| Saku, K | 1 |
| Gartside, PS | 1 |
| Hynd, BA | 1 |
| Mendoza, SG | 1 |
| Kashyap, ML | 1 |
| Rubinstein, A | 1 |
| Gibson, JC | 1 |
| Paterniti, JR | 1 |
| Kakis, G | 1 |
| Little, A | 1 |
| Ginsberg, HN | 1 |
| Brown, WV | 1 |
1 review available for 1-anilino-8-naphthalenesulfonate and Hyperlipoproteinemia Type IV
| Article | Year |
|---|---|
Disorders of lipid transport: relationship to abnormalities of apoproteins, enzymes and cellular receptors.
Topics: Abetalipoproteinemia; Apolipoproteins; Apoproteins; Female; Humans; Hyperlipoproteinemia Type III; H | 1984 |
2 trials available for 1-anilino-8-naphthalenesulfonate and Hyperlipoproteinemia Type IV
| Article | Year |
|---|---|
Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia.
Topics: Adult; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Humans; Hyperlipoproteinemia | 1988 |
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Apolipoproteins B; Choleste | 1985 |
7 other studies available for 1-anilino-8-naphthalenesulfonate and Hyperlipoproteinemia Type IV
| Article | Year |
|---|---|
Human endogenous plasma lipemia clearing activity after intravenous fat emulsions (lipomul).
Topics: Corn Oil; Fat Emulsions, Intravenous; Fats; Humans; Hyperlipoproteinemia Type IV; Infusions, Parente | 1958 |
Human endogenous plasma lipemia clearing activity, observations in 482 individuals.
Topics: Hyperlipoproteinemia Type IV; Lipase; Plasma | 1958 |
Heparin-released lipolytic activity in the forearm vascular bed in patients with hypertriglyceridaemia.
Topics: Adult; Blood Vessels; Forearm; Heparin; Humans; Hyperlipoproteinemia Type IV; Lipase; Lipolysis; Mal | 1982 |
Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and composition of high density lipoproteins.
Topics: Carrier Proteins; Fat Emulsions, Intravenous; Humans; Hyperlipoproteinemia Type IV; Immunoelectropho | 1986 |
Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia.
Topics: Adult; Apolipoproteins; Cholesterol; Electrophoresis, Agar Gel; Heparin; Humans; Hyperlipoproteinemi | 1986 |
Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
Topics: Adult; Animals; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Cattle; Cholesterol; Hep | 1985 |
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Topics: Adult; Apolipoproteins E; Child, Preschool; Female; Heparin; Humans; Hyperlipoproteinemia Type I; Hy | 1985 |